Literature DB >> 2503623

Cell surface expression of several species of human immunodeficiency virus type 1 major core protein.

A G Laurent1, B Krust, M A Rey, L Montagnier, A G Hovanessian.   

Abstract

The major core protein (p25) of the human immunodeficiency virus type 1 (HIV-1) was characterized by two-dimensional-gel isoelectric focusing. The p25 detectable in HIV-1-infected cells is composed of four species with related isoelectric points. This is due in part to the phosphorylated state of p25. The four species of p25 are expressed on the cell surfaces of infected cells, but only the two most basic species are incorporated into the HIV-1 virion. These findings emphasize the importance of p25 in understanding infection with HIV and might have implications for the development of vaccines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503623      PMCID: PMC251010     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Alteration of cell-surface proteins by viral transformation and by proteolysis.

Authors:  R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

4.  Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing.

Authors:  M A Rey; B Krust; A G Laurent; L Montagnier; A G Hovanessian
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

Authors:  W G Robey; B Safai; S Oroszlan; L O Arthur; M A Gonda; R C Gallo; P J Fischinger
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

6.  HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Authors:  B D Walker; S Chakrabarti; B Moss; T J Paradis; T Flynn; A G Durno; R S Blumberg; J C Kaplan; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

Review 7.  Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  M Essex; J Allan; P Kanki; M F McLane; G Malone; L Kitchen; T H Lee
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

8.  Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

Authors:  Y Riviere; F Tanneau-Salvadori; A Regnault; O Lopez; P Sansonetti; B Guy; M P Kieny; J J Fournel; L Montagnier
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.

Authors:  F D Veronese; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

10.  Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation.

Authors:  R B Ferns; R S Tedder; R A Weiss
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

View more
  10 in total

1.  Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.

Authors:  L E Henderson; M A Bowers; R C Sowder; S A Serabyn; D G Johnson; J W Bess; L O Arthur; D K Bryant; C Fenselau
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Preparation and crystallization of a human immunodeficiency virus p24-Fab complex.

Authors:  A J Prongay; T J Smith; M G Rossmann; L S Ehrlich; C A Carter; J McClure
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus.

Authors:  Sarah M Rue; Jason W Roos; Patrick M Tarwater; Janice E Clements; Sheila A Barber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.

Authors:  S H Pincus; R Cole; R Ireland; F McAtee; R Fujisawa; J Portis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation.

Authors:  L M Babé; C S Craik
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

6.  Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.

Authors:  M Niedrig; J Hinkula; H P Harthus; M Bröker; L Hopp; G Pauli; B Wahren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.

Authors:  B F Fernie; G Poli; A S Fauci
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

8.  Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein.

Authors:  R C Craven; A E Leure-duPree; C R Erdie; C B Wilson; J W Wills
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1.

Authors:  Shogo Misumi; Mutsumi Inoue; Takeo Dochi; Naoki Kishimoto; Naomi Hasegawa; Nobutoki Takamune; Shozo Shoji
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

10.  The maturational refolding of the β-hairpin motif of equine infectious anemia virus capsid protein extends its helix α1 at capsid assembly locus.

Authors:  Kang Chen; Grzegorz Piszczek; Carol Carter; Nico Tjandra
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.